NURTEC ODT 75 MG LIOF ORODISP CT BL AL AL X 2

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1211005030017
  • GGREM 522726090096107
  • Código de barras 7891045165747

O que a fonte publica

Detentor do registro
PFIZER BRASIL LTDA
Princípios ativos
HEMISSULFATO DE RIMEGEPANTO SESQUI-HIDRATADO
Embalagem
75 MG LIOF ORODISP CT BL AL AL X 2
Tipo de produto
Novo
Classe terapêutica
N2C2 - ANTAGONISTAS DA CGRP ANTI-ENXAQUECA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:522726090096107
{
  "name": "NURTEC ODT 75 MG LIOF ORODISP CT BL AL AL X 2",
  "holder": "PFIZER BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "7891045165747"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "522726090096107",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "61.072.393/0001-33",
  "priceRegime": "Regulado",
  "productName": "NURTEC ODT",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "75 MG LIOF ORODISP CT BL AL AL X 2",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "181.58",
    "icms-12": "206.34",
    "icms-17": "218.77",
    "icms-18": "221.44",
    "icms-19": "224.17",
    "icms-20": "226.98",
    "icms-21": "229.85",
    "icms-22": "232.79",
    "icms-23": "235.82",
    "icms-17.5": "220.10",
    "icms-19.5": "225.57",
    "icms-20.5": "228.40",
    "icms-22.5": "234.30",
    "icms-12-alc": "184.23",
    "icms-17-alc": "195.33",
    "icms-18-alc": "197.71",
    "icms-19-alc": "200.15",
    "icms-20-alc": "202.66",
    "icms-21-alc": "205.22",
    "icms-22-alc": "207.85",
    "icms-23-alc": "210.55",
    "withoutTaxes": "162.12",
    "icms-17.5-alc": "196.52",
    "icms-19.5-alc": "201.40",
    "icms-20.5-alc": "203.93",
    "icms-22.5-alc": "209.19"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "HEMISSULFATO DE RIMEGEPANTO SESQUI-HIDRATADO",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "243.58",
    "icms-12": "276.80",
    "icms-17": "293.47",
    "icms-18": "297.05",
    "icms-19": "300.72",
    "icms-20": "304.49",
    "icms-21": "308.34",
    "icms-22": "312.28",
    "icms-23": "316.34",
    "icms-17.5": "295.26",
    "icms-19.5": "302.59",
    "icms-20.5": "306.39",
    "icms-22.5": "314.31",
    "icms-12-alc": "254.69",
    "icms-17-alc": "270.03",
    "icms-18-alc": "273.32",
    "icms-19-alc": "276.70",
    "icms-20-alc": "280.17",
    "icms-21-alc": "283.70",
    "icms-22-alc": "287.34",
    "icms-23-alc": "291.07",
    "withoutTaxes": "224.13",
    "icms-17.5-alc": "271.68",
    "icms-19.5-alc": "278.42",
    "icms-20.5-alc": "281.92",
    "icms-22.5-alc": "289.19"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "HEMISSULFATO DE RIMEGEPANTO SESQUI-HIDRATADO"
  ],
  "therapeuticClass": "N2C2 - ANTAGONISTAS DA CGRP ANTI-ENXAQUECA",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1211005030017",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "N2C2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:522726090096107"